#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Chronic lymphocytic leukaemia recurrent Dedifferentiated liposarcoma Growth hormone deficiency Leiomyosarcoma recurrent Antithrombin III deficiency Depression Transitional cell carcinoma Malignant melanoma Myeloid leukaemia Mitochondrial myopathy Small cell lung cancer recurrent Ewing's sarcoma recurrent Vulval cancer recurrent Aspergillus infection ROHHAD syndrome More trials…

    Learn about Rare Diseases

    Anaplastic thyroid cancer – Life with Disease Congenital generalised lipodystrophy – Basic Information Prader-Willi syndrome – Basic Information Angiosarcoma recurrent – Treatment Tuberous sclerosis complex – Trials in Disease Cystic fibrosis lung – Basic Information Hereditary ataxia – Basic Information Hereditary optic atrophy – Diagnostics Progressive supranuclear palsy – Life with Disease Pulmonary sarcoidosis – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Hepatitis B Surface Antigen Apg777 Sotatercept RIMIDUCID Eye103 Pasireotide Diaspartate Betahistine Dihydrochloride Calcium Chloride Dihydrate Oric-114 Pentoxifylline Nilotinib Vrdn-001 A/(H3N2)-LIKE VIRUS ANTIGEN Glucagon Folinic Acid Rtx001 BENZYLPENICILLIN PROCAINE ABY-271 Ifosfamide Digoxin More therapies…

    Learn about Your Condition

    Neuromyopathy Phenylketonuria Obsessive-compulsive disorder Lichenoid keratosis Sciatica Acute HIV infection Prolymphocytic leukaemia Pharyngeal cancer stage I Prostate cancer recurrent Pneumonia Peptostreptococcus infection Lysosomal storage disorder BK virus infection Glomerulonephritis chronic Constipation More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on Personalized vs Non-Personalized Radionuclide Therapy with 177Lu-Edotreotide and Capecitabine for Patients with Neuroendocrine Tumors

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Neuroendocrine tumour
    Investigated Drugs:
    • Lutetium (177Lu) Edotreotide
    • Capecitabine
    Sweden

  • Study of Pembrolizumab and Cabozantinib for Patients with Advanced Sarcomas: Undifferentiated Pleomorphic Sarcoma, Osteosarcoma, and Ewing Sarcoma

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Malignant fibrous histiocytoma
    • Sarcoma
    • Osteosarcoma
    Investigated Drugs:
    • Cabozantinib
    • Pembrolizumab
    France

  • Study on the Effects of Lenomorelin in Patients with Acute Ischemic Stroke Undergoing Endovascular Thrombectomy

    Recruiting

    2 1 1
    Investigated Diseases:
    • Ischaemic stroke
    Investigated Drugs:
    • Lenomorelin
    The Netherlands

  • Evaluation of personalized Iodine-131 therapy using PET imaging in patients with metastatic thyroid cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Thyroid cancer
    Investigated Drugs:
    • Sodium Iodide (131I)
    Italy

  • Study on the Safety and Efficacy of Avalglucosidase Alfa for Patients Aged 5 and Older with Non-Classic Pompe Disease

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Glycogen storage disease type II
    Investigated Drugs:
    • Avalglucosidase Alfa
    The Netherlands

  • Study on Anakinra for Treating Inflammatory Dilated Cardiomyopathy in Patients: Evaluating Efficacy and Safety of Anakinra with Standard Care vs. Standard Care Alone

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Dilated cardiomyopathy
    Investigated Drugs:
    • Anakinra
    Italy
Previous Page
1 … 613 614 615 616 617 … 1,656
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!